MorphoSys AG to Discuss MANIFEST-2 Results Transcript

Nov 21, 2023 / 01:00PM GMT

Thank you for standing by. Welcome, and thank you for joining the Topline Results MANIFEST-2 Study. (Operator Instructions)

I would like to turn the conference over to Julia Neugebauer. Please go ahead, madam.

Julia Neugebauer - MorphoSys AG - Head of IR

Ladies and gentlemen, good afternoon and good morning. Thank you for joining us. It is my pleasure to welcome you to our conference call today where we will be presenting the topline results from our Phase III MANIFEST-2 study of pelabresib in myelofibrosis following yesterday's announcement. You can find our press release and the slides from today's call on the Investors section of our website.

Before we begin, I'd like to remind you on Slide 2 that some of the statements made during the call may contain forward-looking statements, including statements regarding our expectations for the commercialization of our products, our development plans and expectations for the compounds in our pipeline as well as the development plans of our collaboration partners.

These forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot